Can AI Predict Breast Cancer Risk? Yes.

Identify individuals that will benefit the most from supplemental screening.

Go to Demo

Mammography alone can't catch all the cancers.

1 in 12

women will develop breast cancer in their lifetime.

Source
30%

of breast cancers are missed by mammography screening.

Source

Cancer caught between screenings  is

3.5x

times more deadly than screen-detected.

Source

More than

100,000

patients in Europe and US receive a late diagnosis every year.

AISmartDensity image

Meet AISmartDensity®

Intelligent Risk Assessment

AISmartDensity® enhances the breast cancer screening programmes by accurately identifying patients at higher risk of missed breast cancer. Our technology analyses mammograms to select individuals who may benefit from supplemental screening, like MRI.

Image-Based

Mammogram-only input.

Feature 2 Image

Cutting-Edge Deep Learning

Leveraging state-of-the-art vision machine learning models.

Feature 1 Image

Explainable AI

Behind the Model's Decisions

Cancer Detection

Assesses the likelihood of malignant tissue.

Subfeature 1 Image

Long-Term Risk

Evaluates potential for future cancer development.

Subfeature 2 Image

Masking

Assesses the potential of cancer being hidden by surrounding tissue.

Subfeature 3 Image

Clinically-tested effectiveness.

4x

more cancers detected on individuals selected for MRI by AISmartDensity®.

Ours Next best alternative
30%

savings on the cost per detected cancer.

100M+

annual mammograms in Europe and US.

Source

Since

2024

supplemental screening is recommended for individuals with dense breasts in Europe and the US.

In the US In the EU

Improve patient outcomes through targeted screening.

Enhance breast cancer detection and patient care with AISmartDensity®.

Go to Demo